Skip to main content
. 2023 Nov 30;17:260–268. doi: 10.1016/j.xjon.2023.10.039

Table 2.

Pathology data

Histology Grade N (percentage)
Adenocarcinoma Well 8 (30%)
Moderate 6 (22%)
Poor 6 (22%)
Squamous cell cancer Well 1 (4%)
Moderate 1 (4%)
Poor 3 (11%)
Large cell cancer Undifferentiated 1 (4%)
Carcinoid 1 (4%)
Stage T1xN0 (noncarcinoid) 11 (41%)
T2-4N1-2 13 (48%)
T1cN1 1 (4%)
Ipsilateral T1s 1 (4%)
T1N0 carcinoid 1 (4%)

Percentages are based on a baseline “n” of 27 cancer resections, including the patient with the carcinoid tumor.